Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 10 of 23
Biose
Biose
Siparex Territoires
France
Active
Sector
Biotech
InvestorSiparex
Entry
2021
Hold
5yr
bioXXmed AG
bioXXmed AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Germany
Active
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2024
Hold
2yr
bit.bio
bit.bio
BlueYard Capital Fund II
United Kingdom
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2019
Hold
7yr
Bitrobius Genetics
Bitrobius Genetics
UK Innovation and Science Seed Fund
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
2023
Hold
3yr
BiVictriX Therapeutics
BiVictriX Therapeutics
Development Bank of Wales (Balance Sheet)
UK
Active
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2016
Hold
10yr
Bota Bio
Bota Bio
BASF Venture Capital Evergreen Fund
China
Active
Sector
Biotech
InvestorBASF Venture Capital
Entry
2021
Hold
5yr
Botalys
Botalys
ALIAD
Belgium
Active
Sector
Biotech
InvestorAliad Venture Capital
Entry
2022
Hold
4yr
Bright Biotech
Bright Biotech
FoodLabs Fund II
United Kingdom
Active
Sector
Biotech
InvestorFoodLabs
Entry
2022
Hold
4yr
Bright Peak Therapeutics
Bright Peak Therapeutics
TVM Life Science Ventures
Switzerland
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Brink Therapeutics
Brink Therapeutics
Breega Seed fund
France
Active
Sector
Biotech
InvestorBreega
Entry
2025
Hold
1yr
Broken String
Broken String
DvH Ventures Fund IV (Digital Health Fund)
Germany
Active
Sector
Biotech
InvestorDvH Ventures
Entry
2021
Hold
5yr
Capricorn Scientific GmbH
Capricorn Scientific GmbH
Hessen Kapital
Germany
Active
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
Caris Life Sciences
Caris Life Sciences
Silver Lake Partners IV
USA
Active
Sector
Biotech
InvestorSilver Lake
Entry
–
CaSRevolution
CaSRevolution
Utopia SIS
Italy
Active
Sector
Biotech
InvestorUtopia SIS
Entry
2023
Hold
3yr
Cebiotex
Cebiotex
Inveready Biotech II
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
10yr
Celea Therapeutics
Celea Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2026
Hold
0yr
CellCentric
CellCentric
UK Innovation and Science Seed Fund
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
–
CellDrive
CellDrive
BeAble Innvierte KETs Fund
Spain
Active
Sector
Biotech
InvestorBeAble Capital
Entry
2021
Hold
5yr
Cellino Biotech
Cellino Biotech
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Centauri Therapeutics
Centauri Therapeutics
Boehringer Ingelheim Venture Fund
United Kingdom
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2022
Hold
4yr
Cephagenix
Cephagenix
AFB Fund II
Denmark
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2025
Hold
1yr
Cerevance
Cerevance
Dementia Discovery Fund
United States
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2016
Hold
10yr
Cimico
Cimico
Moira Capital Desarrollo
Spain
Active
Sector
Biotech
InvestorMoira Capital Partners
Entry
2023
Hold
3yr
Cleara Biotech
Cleara Biotech
Apollo Health Ventures Fund II
Netherlands
Active
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
clock.bio
clock.bio
BlueYard Capital Fund III
United Kingdom
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
Cocoon Bioscience
Cocoon Bioscience
Columbus Life Sciences Fund IV
Spain
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Code Biotherapeutics
Code Biotherapeutics
4BIO Ventures III
US
Active
Sector
Biotech
Investor4Bio Partners
Entry
2022
Hold
4yr
Concert Bio
Concert Bio
Nucleus Capital I
United Kingdom
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2022
Hold
4yr
Concinnity Genetics
Concinnity Genetics
Old College Capital LP
UK
Active
Sector
Biotech
InvestorOld College Capital
Entry
2024
Hold
2yr
Confo Therapeutics
Confo Therapeutics
Wellington Partners Life Sciences
Belgium
Active
Sector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Congruence Therapeutics
Congruence Therapeutics
Angelini Ventures
Canada
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
Connecta Therapeutics
Connecta Therapeutics
Inveready Biotech III
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2022
Hold
4yr
ConstructiveBio
ConstructiveBio
Amadeus V Technology Fund
UK
Active
Sector
Biotech
InvestorAmadeus Capital Partners
Entry
2022
Hold
4yr
Corat Therapeutics GmbH
Corat Therapeutics GmbH
NBank Capital Beteiligungsfonds
Germany
Active
Sector
Biotech
InvestorNBank Capital
Entry
2020
Hold
6yr
Core Biogenesis
Core Biogenesis
Digital 3
France
Active
Sector
Biotech
InvestorXAnge
Entry
2020
Hold
6yr
Corion Biotech
Corion Biotech
LIFTT
Italy
Active
Sector
Biotech
InvestorLIFTT
Entry
2020
Hold
6yr
CoSyne Therapeutics
CoSyne Therapeutics
Backed Fund II
UK
Active
Sector
Biotech
InvestorBACKED VC
Entry
2022
Hold
4yr
Creasallis
Creasallis
BlueYard Capital Fund III
United Kingdom
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Crucible Therapeutics
Crucible Therapeutics
Northern Gritstone Evergreen
UK
Active
Sector
Biotech
InvestorNorthern Gritstone
Entry
2023
Hold
3yr
CrystalsFirst GmbH
CrystalsFirst GmbH
Technologiefonds Hessen
Germany
Active
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
Cumulus Oncology
Cumulus Oncology
Scottish National Investment Bank (Balance Sheet)
UK
Active
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Curlim
Curlim
AVA 1 (Aquiti Venture Amorcage)
France
Active
Sector
Biotech
InvestorAquiti Gestion
Entry
2024
Hold
2yr
Curve Therapeutics
Curve Therapeutics
Columbus Life Sciences Fund IV
United Kingdom
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
cutanos
cutanos
HTGF III
Austria
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
CV6 Therapeutics
CV6 Therapeutics
Co-Fund NI
UK
Active
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2022
Hold
4yr
CV6 Therapeutics (NI) Ltd
CV6 Therapeutics (NI) Ltd
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2019
Hold
7yr
Cyclarity Therapeutics
Cyclarity Therapeutics
KIZOO Evergreen (Balance Sheet)
United States
Active
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2019
Hold
7yr
Cytoki Pharma
Cytoki Pharma
Ysios BioFund III
DK
Active
Sector
Biotech
InvestorYsios Capital Partners
Entry
2021
Hold
5yr
Damona Pharmaceuticals
Damona Pharmaceuticals
Angelini Ventures
Canada
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
Dilafor
Dilafor
Rosetta Capital IV
Sweden
Active
Sector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr